Milestone Scientific Inc. (NYSE:MLSS – Get Free Report) Director Leonard Osser sold 107,984 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $0.93, for a total value of $100,425.12. Following the transaction, the director now directly owns 4,606,882 shares of the company’s stock, valued at $4,284,400.26. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Leonard Osser also recently made the following trade(s):
- On Wednesday, August 21st, Leonard Osser sold 141,913 shares of Milestone Scientific stock. The shares were sold at an average price of $0.95, for a total value of $134,817.35.
Milestone Scientific Stock Performance
Shares of NYSE MLSS opened at $0.80 on Friday. The stock has a 50 day moving average price of $0.94 and a 200 day moving average price of $0.82. The stock has a market capitalization of $61.55 million, a PE ratio of -7.97 and a beta of 1.08. Milestone Scientific Inc. has a 52 week low of $0.52 and a 52 week high of $1.10.
Analyst Upgrades and Downgrades
MLSS has been the topic of a number of recent research reports. Benchmark began coverage on shares of Milestone Scientific in a report on Thursday, October 10th. They issued a “speculative buy” rating and a $1.25 price objective on the stock. StockNews.com initiated coverage on shares of Milestone Scientific in a research note on Friday. They issued a “hold” rating on the stock.
Get Our Latest Analysis on Milestone Scientific
About Milestone Scientific
Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.
Featured Stories
- Five stocks we like better than Milestone Scientific
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- The Most Important Warren Buffett Stock for Investors: His Own
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Election Stocks: How Elections Affect the Stock Market
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.